Buscar
Mostrando ítems 1-10 de 431
The preclinical discovery and development of opicapone for the treatment of Parkinson’s disease
(Taylor and Francis Ltd, 2020)
Oxfendazole: a promising agent for the treatment and control of helminth infections in humans.
(Taylor and Francis, 2018)
Introduction: Oxfendazole (methyl [5-(phenylsulphinyl)-1H benzimidazole-2-yl] carbamate) has a particularly long metabolic half-life in ruminants, and its metabolite fenbendazole also has anthelminthic action. A very limited ...
Pharmacokinetics of dexmedetomidine administered intravenously in isofluraneanesthetized cats
(2012-02-01)
Objective-To determine the pharmacokinetics of dexmedetomidine administered as a short-duration IV infusion in isoflurane-anesthetized cats. Animals-6 healthy adult domestic female cats. Procedures-Dexmedetomidine hydrochloride ...
Pharmacokinetics of dexmedetomidine administered intravenously in isofluraneanesthetized cats
(2012-02-01)
Objective-To determine the pharmacokinetics of dexmedetomidine administered as a short-duration IV infusion in isoflurane-anesthetized cats. Animals-6 healthy adult domestic female cats. Procedures-Dexmedetomidine hydrochloride ...
Cholinesterase inhibitors for Alzheimer's disease: Multitargeting strategy based on anti-Alzheimer's drugs repositioning
(Bentham Science Publishers, 2019)
Evaluation of ceftiofur-PHBV microparticles in rats
(Dove Medical Press Ltd., 2014)
Pharmacokinetics, safety, and tolerability of oxfendazole in healthy volunteers: A randomized, placebo-controlled first-inhuman single-dose escalation study
(American Society for Microbiology, 2019)
Cysticercosis is a parasitic disease that frequently involves the human central nervous system (CNS), and current treatment options are limited. Oxfendazole, a veterinary medicine belonging to the benzimidazole family of ...
Pharmacokinetic Profile of A New Diclofenac Prodrug without Gastroulcerogenic Effect
(2013-03-01)
Gastrotoxicity is a major problem for long-term therapy with non-steroidal anti-inflammatory drugs (NSAIDs). DICCIC (1-(2,6-dichlorophenyl)indolin-2-one) is a new diclofenac prodrug, which has proven anti-inflammatory ...